Mark & Associates, P.C. | Attorneys at Law

Live chat by Boldchat

By submitting this form I agree to the following disclaimer.

Helping People at Risk Due to Significant Asbestos Exposure

Aware of Severe Side Effects FDA Approves New Gout Drug

On June 12, 2009, the FDA approved Krystexxa, which is manufactured by Savient Pharmaceuticals to treat gout, even though there are deadly side effects associated with using the medication. The FDA has been reviewing the company's drug application since December and has already delayed a decision on the drug once. The ...